Details of the Drug
General Information of Drug (ID: DMIVO8P)
| Drug Name | N-Isopropyl-N'-Hydroxyguanidine | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                        N-ISOPROPYL-N'-HYDROXYGUANIDINE; N-HYDROXY-N'-ISOPROPYLGUANIDIE; 478806-77-8; IHG; AC1L9KDY; SCHEMBL564061; CHEMBL72434; 1-hydroxy-3-isopropylguanidine; SCHEMBL15424726; 1-hydroxy-2-propan-2-ylguanidine; (E)-2-hydroxy-1-isopropylguanidine; ZINC13535998; 2-hydroxy-1-(propan-2-yl)guanidine; AKOS017475215; AKOS011771464; 1-hydroxy-3-(1-methylethyl)guanidine; DB02143; ACM478806778
                        
                     | ||||||||||||||||||||||
| Indication | 
 | ||||||||||||||||||||||
| Drug Type | Small molecular drug | ||||||||||||||||||||||
| Structure |  | ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 117.15 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -0.6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers | 
 | ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
|  Drug Therapeutic Target (DTT) | 
 | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
